Differential effects of Interleukin-12 Interleukin-15, and Interleukin-2 on human immunodeficiency virus type 1 replication in vitro

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 5, 1996, Pages 547-553

  Bayard McNeeley, Marise ^a   Doo, Howard ^a   He, Suhui ^a   Hafner, Alice ^a   Johnson Jr , Warren D ^a   Ho, John L ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; INTERLEUKIN 12; INTERLEUKIN 15;

ADULT; ARTICLE; CELL LINE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0029836426     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.5.547-553.1996     Document Type: Article

References (20)

1. Anderson, M. D., S. Kumaki, M. Ahdieh, J. Bertles, M. Tometsko, A. Loomis, J. Giri, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, V. Valentine, D. N. Shapiro, S. W. Morris, L. S. Park, and D. Cosman. 1995. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 50:29862-29869.
2. Armitage, R. J., B. M. Macduff, J. Eisenman, R. Paxton, and K. H. Grabstein. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:483-490.
3. Aste-Amezaga, M. A., A. D'Andrea, M. Kubin, and G. Trinchieri. 1994. Cooperation of natural killer cell stimulatory factor/interlcukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell. Immunol. 156:480-492.
4. Bamford, R. N, A. J. Grant, J. D. Burton, C. Peters, G. Kurys, C. K. Goldman, J. Brennan, E. Roessler, and T. A. Waldmann. 1994. The intcrleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-ccll proliferation and the induction of lymphocyte-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940-4944.
5. Bernstein, Z. P., M. M. Porter, M. Gould, B. Lipman, E. M. Bluman, C. C. Stewart, R. G. Hewitt, G. Fyfe, B. Poiesz, and M. A. Caligiuri. 1995. Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood 86:3287-3294.
6. Brunda, M. J. 1994. Interleukin-12. J. Leukocyte Biol. 55:201-208.
7. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. Ho. 1995. Virologie and immunologic characterization of long-term survivors of human immunodeficiency virus type-1 infection. N. Engl. J. Med. 332:201-208.
8. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp. Med. 180:1395-1403.
9. Carson, W. E., M. E. ROSS, R. A. Baiocchi, M. J. Marien, N. Bolani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytcs is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:2578-2582.
10. Cassatella, M. A., L. Meda, S. Gasperini, A. D'Andrea, X. Ma, and G. Trinchieri. 1995. Interleukin-12 production by human polymorphonuclcar leukocytes. Eur. J. Immunol. 25:1-5.
11. Chehimi, J., E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
12. Chehimi, J., N. M. Valiante, A. D'Andrea, M. Rengaraju, Z. Rosado, M. Kobayashi, B. Perussia, S. F. Wolf, S. E. Starr, and G. Trinchieri. 1993. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23:1826-1830.
13. Clerici, M., D. R. Lucej, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell mediated immune responses by interleukin-12 in vitro. Science 262:1721-1724.
14. Clerici, M., and G. M. Shearer. 1993. A Th-1/Th-2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-110.
15. Clerici, M., N. I. Stocks, R. A. Zajac, R. N. Boswell, D. R. Lucey, C. S. Via, and G. M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in symptomatic human immunodeficiency virus-seropositive patients. J. Clin. Invest. 84:1892-1899.
16. Collier, A. C., R. W. Coombs, D. A. Schoenfeld, R. L. Bassett, J. Timpone, A. Baruch, M. Jones, K. Facey, C. Whitacre, V. J. McAuliff, H. M. Friedman, T. C. Merigan, R. C. Reichman, C. Hooper, and L. Corey for the AIDS Clinical Trials Group. 1996. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N. Engl. J. Med. 334:1011-1017.
17. Coombs, R. W. 1994. HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS. Clin. Lab. Med. 14:301-311.
18. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and G. Trincheri. 1992. Production of natural killer cell stimulatory factor by peripheral blood mononuclear cells. J. Exp. Med. 176:1387-1398.
19. Desai, B. B., P. M. Quinn, A. G. Wolitzky, P. K. A. Mongini, R. Chizzonite, and M. Gately. 1992. IL-12 receptor: distribution and regulation of receptor expression. J. Immunol. 148:3125-3132.
20. Dewar, R. L., H. C. Highbarger, M. D. Sarmiento, J. A. Todd, M. B. Vasudevachari, R. T. Davey, Jr., J. A. Kovacs, N. P. Salzman, H. C. Lane, and M. S. Urdea. 1994. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170:1172-1179.